Insider Transactions Reported by 18 Insiders of Vistagen Therapeutics, Inc.

Symbol
VTGN on Nasdaq
Location
South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 09 Jan 2025

Vistagen Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Venrock Healthcare Capital Partners II, L.P. 10%+ Owner $35,434,220 12 Jul 2022
Commodore Capital LP 10%+ Owner $2,704,275 04 Oct 2023
H. RALPH SNODGRASS Pres./Chief Scientific Officer $169,741 31 Dec 2021
Shawn Singh President and CEO, Director $79,494 30 Jun 2025
Reid G. Adler Chief Legal Officer $40,885 30 Jun 2025
Mark Alan Smith Chief Medical Officer $34,194 30 Jun 2022
Cynthia Anderson Chief Financial Officer $21,761 30 Jun 2025
Joshua Prince Chief Operating Officer $8,579 31 Dec 2025
JERROLD D. DOTSON Vp, Cfo $6,303 30 Jun 2023
Ann Michelle Cunningham Director 09 Sep 2025
Paul R. Edick Director 27 Oct 2025
Margaret M. FitzPatrick Director 09 Sep 2025
Joanne Curley Director 09 Sep 2025
Mary L. Rotunno Director 09 Sep 2025
Nick B. Tressler Chief Financial Officer 01 Dec 2025
JON S. SAXE Director 09 Sep 2025
JERRY B. GIN Director 06 Sep 2024
Elissa S. Cote Chief Corp Development Officer 23 Jun 2025

Recent Insider Transactions by Companies or Individuals for Vistagen Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.